Follow this exact reviewed peptide identity across selected source lanes.
Official matched intervention · Drug
Copaxone® clinical trials
9 selected ClinicalTrials.gov records carrying the official matched intervention Copaxone® (Drug). PeptideScanner includes the name only where it resolves exactly to the record’s reviewed peptide identity; it does not infer equivalence or treatment effect.
9 selected records.
1 profiles.
ClinicalTrials.gov intervention field.
Cross-source journeys
Explore connected peptide records
Across these connected profiles, PeptideScanner carries 25 selected PubMed records and 11 selected Drugs@FDA applications. That profile context is not a claim that those records concern this intervention or establish treatment effect.
Collection change ledger
Recently changed records on this intervention hub
These events come only from the exact registry records shown on this page. A matched intervention name does not establish equivalence, safety, effectiveness, or treatment effect.
ClinicalTrials.gov record NCT00078338
PeptideScanner retained ClinicalTrials.gov record NCT00078338 at 2026-11-16T17:42:50.457Z. Its registry update date was 2018-06-27, and PeptideScanner's reviewed identity mapping was glatiramer-acetate.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- June 27, 2018
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT00203021
PeptideScanner retained ClinicalTrials.gov record NCT00203021 at 2026-11-16T17:42:50.457Z. Its registry update date was 2020-02-18, and PeptideScanner's reviewed identity mapping was glatiramer-acetate.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- February 18, 2020
- Evidence lane
- Clinical trials
ClinicalTrials.gov record NCT00337779
PeptideScanner retained ClinicalTrials.gov record NCT00337779 at 2026-11-16T17:42:50.457Z. Its registry update date was 2011-10-10, and PeptideScanner's reviewed identity mapping was glatiramer-acetate.
- PeptideScanner change date
- November 16, 2026
- Cited source date
- October 10, 2011
- Evidence lane
- Clinical trials
Attributed registry records
Selected records
Glatiramer acetate · 2021-12-09
ClinicalTrials.gov record NCT02499900
Completed at the retained observation.
Open attributed record →Glatiramer acetate · 2020-02-18
ClinicalTrials.gov record NCT00203021
Completed at the retained observation.
Open attributed record →Glatiramer acetate · 2018-06-27
ClinicalTrials.gov record NCT00078338
Completed at the retained observation.
Open attributed record →Glatiramer acetate · 2016-01-14
ClinicalTrials.gov record NCT01874145
Completed at the retained observation.
Open attributed record →Glatiramer acetate · 2013-10-17
ClinicalTrials.gov record NCT01167426
Completed at the retained observation.
Open attributed record →Glatiramer acetate · 2012-12-31
ClinicalTrials.gov record NCT00811395
Completed at the retained observation.
Open attributed record →Glatiramer acetate · 2012-11-06
ClinicalTrials.gov record NCT00475865
Completed at the retained observation.
Open attributed record →Glatiramer acetate · 2012-06-25
ClinicalTrials.gov record NCT00666224
Completed at the retained observation.
Open attributed record →Glatiramer acetate · 2011-10-10
ClinicalTrials.gov record NCT00337779
Completed at the retained observation.
Open attributed record →